Proposed Information Collection; Comment Request; Expenditures Incurred by Recipients of Bio-Medical Research and Development Awards From the National Institutes of Health (NIH), 49254-49255 [E7-16965]
Download as PDF
49254
Federal Register / Vol. 72, No. 166 / Tuesday, August 28, 2007 / Notices
estimate. These tables and charts are
available as Adobe Acrobat files.
• Thematic Maps—Display
geographic variation in map format from
the geographic ranking tables.
• Geographic Comparison Tables—
These are single-variable tables
comparing key indicators for
geographies other than States.
• Subject Tables—These tables
highlight a particular subject of interest.
• Selected Population Profiles—Data
profiles for selected population groups.
• Public Use Microdata Sample File
(PUMS)—Computerized files containing
record-level data that can be used to
create custom analyses. The geography
on these files is the same as the PUMS
that were defined for the Census 2000
Sample PUMS files.
Please go to the American FactFinder
(AFF) Web site to review each data
product in detail. Users can access the
AFF from the Census Bureau’s home
page at https://www.census.gov/., or from
the AFF link on the ACS home page at
https://www.census.gov/acs/www/. Users
can view and download each data
product. If you have questions about
any of these data products, please
contact the individual listed in the FOR
FURTHER INFORMATION CONTACT section of
this notice.
Paperwork Reduction Act
pwalker on PROD1PC71 with NOTICES
Notwithstanding any other provision
of law, no person is required to respond
to, nor shall a person be subject to a
penalty for failure to comply with, a
collection of information subject to
requirements of the Paperwork
Reduction Act (PRA), unless that
collection of information displays a
current, valid Office of Management and
Budget (OMB) control number. In
accordance with the PRA, 44 United
States Code, Chapter 35, the OMB
approved the ACS survey under OMB
Control Number 0607–0810. We will
furnish report forms to organizations
included in the survey, and additional
copies will be available upon written
request to the Director, U.S. Census
Bureau, Washington, DC 20233–0101.
Dated: August 21, 2007.
Charles Louis Kincannon,
Director, Bureau of the Census.
[FR Doc. E7–16850 Filed 8–27–07; 8:45 am]
BILLING CODE 3510–07–P
VerDate Aug<31>2005
19:52 Aug 27, 2007
Jkt 211001
DEPARTMENT OF COMMERCE
Bureau of Economic Analysis
Proposed Information Collection;
Comment Request; Expenditures
Incurred by Recipients of Bio-Medical
Research and Development Awards
From the National Institutes of Health
(NIH)
ACTION:
Notice.
SUMMARY: The Department of
Commerce, as part of its continuing
effort to reduce paperwork and
respondent burden, invites the general
public and other Federal agencies to
comment on proposed and/or
continuing information collections, as
required by the Paperwork Reduction
Act of 1995, Public Law 104–13 (44
U.S.C. 3506(c)(2)(A)).
DATES: Written comments must be
submitted on or before 5 p.m. October
29, 2007.
ADDRESSES: Direct all written comments
to Diana Hynek, Departmental
Paperwork Clearance Officer,
Department of Commerce, Room 6625,
14th and Constitution Avenue, NW.,
Washington, DC 20230, or via e-mail at
dhynek@doc.gov.
FOR FURTHER INFORMATION CONTACT:
Charlotte Anne Bond, Government
Fixed Assets Branch, Government
Division (BE–57), Bureau of Economic
Analysis, U.S. Department of
Commerce, Washington, DC 20230;
phone: (202) 606–5581; fax: (202) 606–
5369; or via e-mail at
CharlotteAnne.Bond@bea.gov.
SUPPLEMENTARY INFORMATION:
I. Abstract
The Bureau of Economic Analysis
(BEA) will administer a survey to obtain
the distribution of expenditures
incurred by recipients of bio-medical
research awards from the National
Institutes of Health Research (NIH) and
will provide information on how the
NIH award amounts are expended
across several major categories. This
information, along with wage and price
data from other published sources, will
be used to generate the Bio-medical
Research and Developmental Price
Index (BRDPI). BEA develops this index
for NIH under a reimbursable contract.
The BRDPI is an index of prices paid for
the labor, supplies, equipment, and
other inputs required to perform the biomedical research the NIH supports in its
intramural laboratories and through its
awards to extramural organizations. The
BRDPI is a vital tool for planning the
NIH research budget and analyzing
future NIH programs. A survey of award
PO 00000
Frm 00008
Fmt 4703
Sfmt 4703
recipient entities is currently the only
means for updating the expenditure
categories that are used to prepare the
BRDPI.
II. Authority
This survey will be voluntary. The
authority for NIH to collect information
for the BRDPI is provided in 45 CFR
subpart C, Post-Award Requirements,
section 74.21. This sets forth explicit
standards for grantees in establishing
and maintaining financial management
systems and records, and section 74.53
which provides for the retention of such
records as well as NIH access to such
records.
BEA will administer the survey and
analyze the survey results on behalf of
NIH, through an interagency agreement
between the two agencies. The authority
for the NIH to contract with DOC is the
Economy Act (31 U.S.C. 1535 and 1536).
The ‘‘Special Studies’’ authority, 15
U.S.C. 1525 (first paragraph), permits
DOC to provide, upon the request of any
person, firm or public or private
organization (a) Special studies on
matters within the authority of the
Department of Commerce, including
preparing from its records special
compilations, lists, bulletins, or reports,
and (b) furnishing transcripts or copies
of its studies, compilations and other
records. BEA has programmatic
authority to perform this work pursuant
to 15 U.S.C. 1527a. NIH’s support for
this research is consistent with the
Agency’s duties and authority under 42
U.S.C. 282.
The information provided by the
respondents will be held confidential
and be used for exclusively statistical
purposes. This pledge of confidentiality
is made under the Confidential
Information Protection provisions of
title V, subtitle A, Public Law 107–347.
Title V is the Confidential Information
Protection and Statistical Efficiency Act
of 2002 (CIPSEA). Section 512 (on
Limitations on Use and Disclosure of
Data and Information) of the Act,
provides that ‘‘data or information
acquired by an agency under a pledge of
confidentiality and for exclusively
statistical purposes shall be used by
officers, employees, or agents of the
agency exclusively for statistical
purposes. Data or information acquired
by an agency under a pledge of
confidentiality for exclusively statistical
purposes shall not be disclosed by an
agency in identifiable form, for any use
other than an exclusively statistical
purpose, except with the informed
consent of the respondent.’’
Responses will be kept confidential
and will not be disclosed in identifiable
form to anyone other than employees or
E:\FR\FM\28AUN1.SGM
28AUN1
Federal Register / Vol. 72, No. 166 / Tuesday, August 28, 2007 / Notices
agents of BEA without prior written
permission of the person filing the
report. By law, each employee as well
as each agent is subject to a jail term of
up to 5 years, a fine of up to $250,000,
or both for disclosing to the public any
identifiable information that is reported
about a business or institution.
Section 515 of the Information
Quality Guidelines applies to this
survey. The collection and use of this
information complies with all
applicable information quality
guidelines, i.e., those of the Office of
Management and Budget, Department of
Commerce, and BEA.
III. Method of Collection
A survey with a cover letter that
includes a brief description of, and
rationale for, the survey will be sent by
e-mail to potential respondents by the
first week of June of each year. A report
of the respondent’s expenditures of the
NIH award amounts, following the
proposed format for expenditure
categories included with the survey’s
cover letter, will be requested to be
completed and submitted online no
later than 60 days after mailing. Survey
respondents will be selected on the
basis of award levels, which determine
the weight of the respondent in the biomedical research and development price
index. Potential respondents will
include (1) the top 100 organizations in
total awards, which account for about
74 percent of total awards; (2) 40
additional organizations that are not
primarily in the ‘‘Research and
Development (R&D) contracts’’ category;
and (3) 10 additional organizations that
are primarily in the ‘‘R&D contracts’’
category.
IV. Data
OMB Number: 0608–0069.
Form Number: None.
Type of Review: Regular submission.
Affected Public: Universities or other
organizations that are NIH award
recipients.
Estimated Number of Respondents:
90.
Estimated Time per Response: 11
hours and 12 minutes.
Estimated Total Annual Burden
Hours: 1,008.
Estimated Total Annual Cost:
$41,610.
pwalker on PROD1PC71 with NOTICES
V. Request for Comments
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the NIH, including
whether the information has practical
utility: (b) the accuracy of the agency’s
estimate of the burden (including hours
VerDate Aug<31>2005
19:52 Aug 27, 2007
Jkt 211001
and cost) of the proposed collection of
information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Comments submitted in response to
this notice will be summarized and/or
included in the request for OMB
approval of this information collection;
They also will become a matter of
public record.
Dated: August 22, 2007.
Gwellnar Banks,
Management Analyst, Office of the Chief
Information Officer.
[FR Doc. E7–16965 Filed 8–27–07; 8:45 am]
BILLING CODE 3510–EA–P
DEPARTMENT OF COMMERCE
Foreign–Trade Zones Board
[Docket 38–2007]
Foreign–Trade Zone 7—Mayaguez,
Puerto Rico, Application for Subzone,
MOVA Pharmaceutical Corporation
(Pharmaceutical Manufacturing),
´
Manatı, Puerto Rico
An application has been submitted to
the Foreign–Trade Zones (FTZ) Board
(the Board) by the Puerto Rico Industrial
Development Company, grantee of FTZ
7, requesting special–purpose subzone
status with manufacturing authority for
pharmaceutical products at the
pharmaceutical manufacturing facility
of MOVA Pharmaceutical Corporation
(MOVA), located in Manat´, Puerto Rico.
The application was submitted pursuant
to the Foreign–Trade Zones Act, as
amended (19 U.S.C. 81a–81u), and the
regulations of the Board (15 CFR part
400). It was formally filed on August 14,
2007.
The proposed subzone facility (104
acres, 17 buildings totaling 410, 000 sq.
ft., 40 percent of which is devoted to
manufacturing) is located at State Road
670, Km 2.7 in Manat´, Puerto Rico. The
company has indicated that the square
footage of the buildings devoted to
manufacturing operations could
increase to include up to 70 percent of
the total in the near future.
The MOVA facility (310 employees)
has requested authority to manufacture
two pharmaceutical products, Januvia/
MK–431A (HTSUS 3004.90) and
sitagliptin (HTSUS 2933.59), on behalf
of Merck, Sharpe & Dohme Quimica de
Puerto Rico, Inc. Duty rates on the
finished products range from duty–free
PO 00000
Frm 00009
Fmt 4703
Sfmt 4703
49255
to 6.5 percent, ad valorem. Foreign–
origin material inputs to be used in the
manufacturing process (up to 25 percent
of total materials, by value) include
sitagliptin (HTSUS 2933.59), metformin
hydrochloride (HTSUS 2925.20),
enamine amide (HTSUS 2933.59), and
butyl josphos (HTSUS 2931.00), which
have duty rates of 3.7 percent to 6.5
percent, ad valorem.
The application also requests
authority to include a broad range of
inputs and finished pharmaceutical
products that MOVA may produce
under FTZ procedures in the future. (As
required by the Board’s regulations, new
major activity involving these inputs/
products would require review by the
Board.) The duty rates for these inputs
and final products range from duty–free
to 10 percent.
FTZ procedures would exempt
MOVA from customs duty payments on
foreign materials used in export
production to non–NAFTA countries.
Some 30 to 40 percent of the plant’s
shipments are exported. On its domestic
shipments and sales to NAFTA
countries, MOVA could defer duty until
the products are entered for
consumption or exported, and choose
the lower duty rate that applies to the
finished product for the foreign
components used in production. The
company may also realize certain
logistical/procedural savings related to
zone–to zone transfers and direct
delivery procedures as well as savings
on materials that become scrap/waste
during manufacturing. The application
indicates that FTZ procedures would
help improve the plant’s international
competitiveness.
In accordance with the Board’s
regulations, a member of the FTZ staff
has been designated examiner to
investigate the application and report to
the Board.
Public comment is invited from
interested parties. Submissions (original
and 3 copies) shall be addressed to the
Board’s Executive Secretary at the
address below. The closing period for
their receipt is October 29, 2007.
Rebuttal comments in response to
material submitted during the foregoing
period may be submitted during the
subsequent 15-day period (to November
13, 2007).
A copy of the application will be
available for public inspection at each of
the following locations: U.S.
Department of Commerce Export
Assistance Center, Centro Internacional
de Mercado, Tower II, Suite 702, Road
165, Guaynabo, Puerto Rico, 00968–
8058; and, Office of the Executive
Secretary, Foreign–Trade Zones Board,
Room 2111, U.S. Department of
E:\FR\FM\28AUN1.SGM
28AUN1
Agencies
[Federal Register Volume 72, Number 166 (Tuesday, August 28, 2007)]
[Notices]
[Pages 49254-49255]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-16965]
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
Bureau of Economic Analysis
Proposed Information Collection; Comment Request; Expenditures
Incurred by Recipients of Bio-Medical Research and Development Awards
From the National Institutes of Health (NIH)
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Department of Commerce, as part of its continuing effort
to reduce paperwork and respondent burden, invites the general public
and other Federal agencies to comment on proposed and/or continuing
information collections, as required by the Paperwork Reduction Act of
1995, Public Law 104-13 (44 U.S.C. 3506(c)(2)(A)).
DATES: Written comments must be submitted on or before 5 p.m. October
29, 2007.
ADDRESSES: Direct all written comments to Diana Hynek, Departmental
Paperwork Clearance Officer, Department of Commerce, Room 6625, 14th
and Constitution Avenue, NW., Washington, DC 20230, or via e-mail at
dhynek@doc.gov.
FOR FURTHER INFORMATION CONTACT: Charlotte Anne Bond, Government Fixed
Assets Branch, Government Division (BE-57), Bureau of Economic
Analysis, U.S. Department of Commerce, Washington, DC 20230; phone:
(202) 606-5581; fax: (202) 606-5369; or via e-mail at
CharlotteAnne.Bond@bea.gov.
SUPPLEMENTARY INFORMATION:
I. Abstract
The Bureau of Economic Analysis (BEA) will administer a survey to
obtain the distribution of expenditures incurred by recipients of bio-
medical research awards from the National Institutes of Health Research
(NIH) and will provide information on how the NIH award amounts are
expended across several major categories. This information, along with
wage and price data from other published sources, will be used to
generate the Bio-medical Research and Developmental Price Index
(BRDPI). BEA develops this index for NIH under a reimbursable contract.
The BRDPI is an index of prices paid for the labor, supplies,
equipment, and other inputs required to perform the bio-medical
research the NIH supports in its intramural laboratories and through
its awards to extramural organizations. The BRDPI is a vital tool for
planning the NIH research budget and analyzing future NIH programs. A
survey of award recipient entities is currently the only means for
updating the expenditure categories that are used to prepare the BRDPI.
II. Authority
This survey will be voluntary. The authority for NIH to collect
information for the BRDPI is provided in 45 CFR subpart C, Post-Award
Requirements, section 74.21. This sets forth explicit standards for
grantees in establishing and maintaining financial management systems
and records, and section 74.53 which provides for the retention of such
records as well as NIH access to such records.
BEA will administer the survey and analyze the survey results on
behalf of NIH, through an interagency agreement between the two
agencies. The authority for the NIH to contract with DOC is the Economy
Act (31 U.S.C. 1535 and 1536).
The ``Special Studies'' authority, 15 U.S.C. 1525 (first
paragraph), permits DOC to provide, upon the request of any person,
firm or public or private organization (a) Special studies on matters
within the authority of the Department of Commerce, including preparing
from its records special compilations, lists, bulletins, or reports,
and (b) furnishing transcripts or copies of its studies, compilations
and other records. BEA has programmatic authority to perform this work
pursuant to 15 U.S.C. 1527a. NIH's support for this research is
consistent with the Agency's duties and authority under 42 U.S.C. 282.
The information provided by the respondents will be held
confidential and be used for exclusively statistical purposes. This
pledge of confidentiality is made under the Confidential Information
Protection provisions of title V, subtitle A, Public Law 107-347. Title
V is the Confidential Information Protection and Statistical Efficiency
Act of 2002 (CIPSEA). Section 512 (on Limitations on Use and Disclosure
of Data and Information) of the Act, provides that ``data or
information acquired by an agency under a pledge of confidentiality and
for exclusively statistical purposes shall be used by officers,
employees, or agents of the agency exclusively for statistical
purposes. Data or information acquired by an agency under a pledge of
confidentiality for exclusively statistical purposes shall not be
disclosed by an agency in identifiable form, for any use other than an
exclusively statistical purpose, except with the informed consent of
the respondent.''
Responses will be kept confidential and will not be disclosed in
identifiable form to anyone other than employees or
[[Page 49255]]
agents of BEA without prior written permission of the person filing the
report. By law, each employee as well as each agent is subject to a
jail term of up to 5 years, a fine of up to $250,000, or both for
disclosing to the public any identifiable information that is reported
about a business or institution.
Section 515 of the Information Quality Guidelines applies to this
survey. The collection and use of this information complies with all
applicable information quality guidelines, i.e., those of the Office of
Management and Budget, Department of Commerce, and BEA.
III. Method of Collection
A survey with a cover letter that includes a brief description of,
and rationale for, the survey will be sent by e-mail to potential
respondents by the first week of June of each year. A report of the
respondent's expenditures of the NIH award amounts, following the
proposed format for expenditure categories included with the survey's
cover letter, will be requested to be completed and submitted online no
later than 60 days after mailing. Survey respondents will be selected
on the basis of award levels, which determine the weight of the
respondent in the bio-medical research and development price index.
Potential respondents will include (1) the top 100 organizations in
total awards, which account for about 74 percent of total awards; (2)
40 additional organizations that are not primarily in the ``Research
and Development (R&D) contracts'' category; and (3) 10 additional
organizations that are primarily in the ``R&D contracts'' category.
IV. Data
OMB Number: 0608-0069.
Form Number: None.
Type of Review: Regular submission.
Affected Public: Universities or other organizations that are NIH
award recipients.
Estimated Number of Respondents: 90.
Estimated Time per Response: 11 hours and 12 minutes.
Estimated Total Annual Burden Hours: 1,008.
Estimated Total Annual Cost: $41,610.
V. Request for Comments
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the NIH, including whether the information has practical utility: (b)
the accuracy of the agency's estimate of the burden (including hours
and cost) of the proposed collection of information; (c) ways to
enhance the quality, utility, and clarity of the information to be
collected; and (d) ways to minimize the burden of the collection of
information on respondents, including through the use of automated
collection techniques or other forms of information technology.
Comments submitted in response to this notice will be summarized
and/or included in the request for OMB approval of this information
collection; They also will become a matter of public record.
Dated: August 22, 2007.
Gwellnar Banks,
Management Analyst, Office of the Chief Information Officer.
[FR Doc. E7-16965 Filed 8-27-07; 8:45 am]
BILLING CODE 3510-EA-P